A new trading day began on Tuesday, with Mereo Biopharma Group Plc ADR (NASDAQ: MREO) stock price up 5.65% from the previous day of trading, before settling in for the closing price of $1.77. MREO’s price has ranged from $1.47 to $4.39 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 34.82% over the past five years. Meanwhile, its annual earnings per share averaged 18.75%. With a float of $131.27 million, this company’s outstanding shares have now reached $159.00 million.
Mereo Biopharma Group Plc ADR (MREO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Mereo Biopharma Group Plc ADR is 17.44%, while institutional ownership is 53.56%.
Mereo Biopharma Group Plc ADR (MREO) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.01 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.92% during the next five years compared to 34.82% growth over the previous five years of trading.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Trading Performance Indicators
Here are Mereo Biopharma Group Plc ADR’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.13. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 583.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.32, a number that is poised to hit 0.00 in the next quarter and is forecasted to reach -0.02 in one year’s time.
Technical Analysis of Mereo Biopharma Group Plc ADR (MREO)
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) saw its 5-day average volume 1.65 million, a positive change from its year-to-date volume of 1.63 million. As of the previous 9 days, the stock’s Stochastic %D was 42.44%.
During the past 100 days, Mereo Biopharma Group Plc ADR’s (MREO) raw stochastic average was set at 25.32%, which indicates a significant decrease from 44.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1175 in the past 14 days, which was higher than the 0.1120 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.9058, while its 200-day Moving Average is $2.2220. Nevertheless, the first resistance level for the watch stands at $1.9402 in the near term. At $2.0105, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0909. If the price goes on to break the first support level at $1.7895, it is likely to go to the next support level at $1.7091. The third support level lies at $1.6388 if the price breaches the second support level.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Key Stats
With a market capitalization of 297.33 million, the company has a total of 159,000K Shares Outstanding. Currently, annual sales are 0 K while annual income is -43,250 K. The company’s previous quarter sales were 500 K while its latest quarter income was -14,620 K.
